Showing results (531-540 of 652) with videos related to
Sort By:
Pageof 66
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 25, 2015
Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Réanimation Respiratoire en Onco-HématologieMichael Darmon, François Vincent, Emmanuel Canet, et al.Intensive Care Medicine|October 22, 2023
Magnesium sulphate in patients with thrombotic thrombocytopenic purpura (MAGMAT): a randomised, double-blind, superiority trialLara Zafrani, Emmanuel Canet, Anouk Walter-Petrich, et al.Haematologica|July 21, 2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL groupLionel Adès, Xavier Thomas, Agnes Guerci Bresler, et al.Haematologica|October 14, 2011
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des MyelodysplasiesLionel Adès, Fabien Le Bras, Marie Sebert, et al.American Journal of Obstetrics and Gynecology|May 26, 2006
Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected populationPatrick Rozenberg, Laurence Bussières, Sylvie Chevret, et al.Journal of Clinical Medicine|April 3, 2021
Cancer Patients' Prehospital Emergency Care: Post Hoc Analysis from the French Prospective Multicenter Study EPICANCEROlivier Peyrony, Jean-Paul Fontaine, Eloïse Trabattoni, et al.Oncotarget|February 5, 2011
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndromeEmmanuel Raffoux, Audrey Cras, Christian Recher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia GroupLionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.Blood|April 17, 2015
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemiaYves Chalandon, Xavier Thomas, Sandrine Hayette, et al.American Journal of Hematology|April 9, 2013
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patientsLionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.Pageof 66